Skip to content

Stevia Extract and Glucose Homeostasis

Effect of Stevia Extract on Postprandial Glucose Response and Satiety in Overweight and Obese Adults: A Three-arm Crossover Trial.

Status
Withdrawn
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04335565
Enrollment
0
Registered
2020-04-06
Start date
2020-03-03
Completion date
2021-02-15
Last updated
2021-05-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity, Overweight

Keywords

Non-nutritive sweeteners, postprandial glucose, diabetes, obesity, satiety

Brief summary

This study aims to assess the effect of stevia extract on postprandial glucose and insulin levels in overweight and obese adults when compared to sugar and water.

Detailed description

The study is a three-arm crossover trial involving participants attending the Lab on 3 different occasions (separated by 3-5 day washout period), where they will be administered water, sugar solution (65g), water and stevia extract (5g) solution. The solution will be followed by a consumption of a fixed meal (after 30 minutes). Breakfast will be standardised. Capillary blood glucose will be collected every 30 min until 2 hours post meal. Venous blood samples will be collected before the intake of the solution and at 2 hours after meal intake.

Interventions

OTHERsugar replacements

Participants will receive a solution of stevia before being administered a fixed meal (lunch). Glucose and insulin levels, and Visual analogue scale data will be collected.

Sponsors

Liverpool Hope University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
PREVENTION
Masking
SINGLE (Subject)

Masking description

Single (participant)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Age 18-65 years * BMI 27-40 Kg/m2 * Males and females

Exclusion criteria

* Athletes * Pregnant or breastfeeding women * Patients with chronic disease (diabetes, CVD etc…).

Design outcomes

Primary

MeasureTime frameDescription
Postprandial glucose levelsCapillary blood glucose will be measured two hours after the administration of a fixed meal.Change in glucose levels two hours after the administration of a fixed meal

Secondary

MeasureTime frameDescription
Postprandial insulin levelsPostprandial insulin levels will be measured two hours of the administration of a fixed mealChange in postprandial insulin levels two hours after the administration of a fixed meal
Area under the curve (AUC) for glucoseCapillary blood glucose levels will be collected 6 times on each visit before the intake of the solution until 2 hours post lunchChanges in AUC for glucose throughout the intervention
Subjective feelings of satietyVAS will be collected 6 times on each visit before the intake of the solution until 2 hours post lunch.Visual analogue scales

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026